Page last updated: 2024-08-25

epristeride and Carcinoma, Transitional Cell

epristeride has been researched along with Carcinoma, Transitional Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, CK; Chan, LW; Chan, SF; Chan, SY; Cheng, CW; Cheung, HY; Lai, FM; Li, ML; Ng, CF; To, KF; Wong, WS	1

Trials

1 trial(s) available for epristeride and Carcinoma, Transitional Cell

Article	Year
Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer. International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Androstadienes; BCG Vaccine; Carcinoma, Transitional Cell; Cross-Over Studies; Cystectomy; Cystoscopy; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms	2005

Article

Year

Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.

International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:5

Topics: 5-alpha Reductase Inhibitors; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Androstadienes; BCG Vaccine; Carcinoma, Transitional Cell; Cross-Over Studies; Cystectomy; Cystoscopy; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms

2005